Melissa’s work focuses on the translation of basic science into preclinical research and longer term clinical outcomes. The preclinical developmental and safety trials, including first-in-human studies that Melissa has completed and been involved in, have been pivotal for both the commercialisation and transfer of knowledge for a number of cardiovascular devices for use in the clinical setting.